A review of 250 prediction models for survival and mortality in adults 65+ with cancer found major methodological flaws that prevent clinical use. Conducted by the ACADI group and SIOG members, the study highlights a gap between current models and real-world applicability, calling for more robust approaches to improve risk prediction.